Simple blood test could spot breast cancer earlier

NCT ID NCT06529614

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new blood test that looks for tiny molecules called MicroRNA in people with breast cancer. The goal is to see how accurate the test is at detecting the disease. Researchers will compare results from 100 participants, including healthy volunteers, to measure the test's sensitivity and specificity.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

In-situ detection method for Micro-RNA

What this could lead to

If successful, this could provide a new, simpler blood test to help detect breast cancer earlier.

What could go wrong

This is a small, early-stage study (100 participants) testing a new method. It may not prove accurate enough for widespread use, and results may not apply to all patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tongji Hospital

    RECRUITING

    Wuhan, Hubei, 430030, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••